Early Access

10-Q/APeriod: Q2 FY2010

Elevance Health, Inc. Quarterly Report (Amendment) for Q2 Ended Jun 30, 2010

Filed August 3, 2010For Securities:ELV

Summary

This filing is an amendment to Elevance Health, Inc.'s (formerly WellPoint, Inc.) Form 10-Q for the quarterly period ended June 30, 2010. The primary purpose of this amendment is to furnish XBRL-formatted interactive data files, including consolidated financial statements and notes. It does not introduce new financial information or reflect events subsequent to the original filing date. Therefore, investors should refer to the original 10-Q filing for substantive financial performance analysis and operational updates for the period. As this is an amendment solely for XBRL data, it's crucial for investors to look at the original 10-Q filing from August 3, 2010, which contains the actual financial and operational details. This amendment ensures compliance with SEC interactive data requirements but provides no new insights into the company's business performance, strategic initiatives, or financial condition beyond what was originally reported.

Financial Statements
Beta
Revenue$14.43B
SG&A Expenses$2.15B
Operating Income$1.06B
Interest Expense$100.20M
Net Income$722.40M
EPS (Basic)$1.73
EPS (Diluted)$1.71
Shares Outstanding (Basic)417.30M
Shares Outstanding (Diluted)421.80M

Key Highlights

  • 1This filing is an amendment (10-Q/A) to the quarterly report for the period ended June 30, 2010.
  • 2The amendment's sole purpose is to provide XBRL-formatted interactive data files (Exhibit 101).
  • 3No new financial information or updates to disclosures are included in this amendment.
  • 4The original Form 10-Q filing should be consulted for actual financial performance and operational details.
  • 5The company is identified as WellPoint, Inc. in this filing.
  • 6Elevance Health (WellPoint) is a large accelerated filer.
  • 7The filing confirms the company has submitted interactive data files for the preceding 12 months.

Frequently Asked Questions